Reglagene Selected to Participate in Johnson & Johnson Innovation Quick Pitch

Updated: Feb 27, 2020

Reglagene was one of 10 companies selected out of more than 300 applicants to pitch leaders from across Johnson & Johnson Innovation during the 2019 J.P. Morgan Healthcare Conference. JPM Week occurs annually in January and is the largest gathering of the pharma, biotech, and investor sectors. Johnson & Johnson Innovation launched the Quick Pitch to unearth the unseen and brightest innovations in healthcare. During the event on January 9, 2019, Reglagene made a tightly woven and compelling presentation that also served as the basis for conversations with prospective investors and pharmaceutical partners throughout the week. After the presentation, Johnson & Johnson awarded Reglagene a trophy for its participation. Reglagene’s CSO Laurence Hurley and CEO Richard Austin proudly pose with the prize.

Recent Posts

See All

Many thanks to Tech Launch Arizona for licensing cancer fighting technology from Dr. Hurley's lab to Reglagene. It has been applied to fighting brain cancer, and is expected to enter the clinic next y